vs

Side-by-side financial comparison of biote Corp. (BTMD) and HEALTHSTREAM INC (HSTM). Click either name above to swap in a different company.

HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $46.4M, roughly 1.7× biote Corp.). On growth, HEALTHSTREAM INC posted the faster year-over-year revenue change (7.4% vs -6.9%). HEALTHSTREAM INC produced more free cash flow last quarter ($13.0M vs $6.5M). Over the past eight quarters, HEALTHSTREAM INC's revenue compounded faster (4.7% CAGR vs -0.4%).

biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.

HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.

BTMD vs HSTM — Head-to-Head

Bigger by revenue
HSTM
HSTM
1.7× larger
HSTM
$79.7M
$46.4M
BTMD
Growing faster (revenue YoY)
HSTM
HSTM
+14.2% gap
HSTM
7.4%
-6.9%
BTMD
More free cash flow
HSTM
HSTM
$6.5M more FCF
HSTM
$13.0M
$6.5M
BTMD
Faster 2-yr revenue CAGR
HSTM
HSTM
Annualised
HSTM
4.7%
-0.4%
BTMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTMD
BTMD
HSTM
HSTM
Revenue
$46.4M
$79.7M
Net Profit
$2.0M
Gross Margin
Operating Margin
14.7%
3.0%
Net Margin
4.2%
Revenue YoY
-6.9%
7.4%
Net Profit YoY
-47.2%
EPS (diluted)
$0.05
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTMD
BTMD
HSTM
HSTM
Q4 25
$46.4M
$79.7M
Q3 25
$48.0M
$76.5M
Q2 25
$48.9M
$74.4M
Q1 25
$49.0M
$73.5M
Q4 24
$49.8M
$74.2M
Q3 24
$51.4M
$73.1M
Q2 24
$49.2M
$71.6M
Q1 24
$46.8M
$72.8M
Net Profit
BTMD
BTMD
HSTM
HSTM
Q4 25
$2.0M
Q3 25
$8.2M
$6.1M
Q2 25
$3.2M
$5.4M
Q1 25
$13.7M
$4.3M
Q4 24
$3.7M
Q3 24
$10.7M
$5.7M
Q2 24
$-7.1M
$4.2M
Q1 24
$-4.2M
$5.2M
Operating Margin
BTMD
BTMD
HSTM
HSTM
Q4 25
14.7%
3.0%
Q3 25
17.2%
9.9%
Q2 25
22.0%
7.9%
Q1 25
19.8%
6.0%
Q4 24
5.6%
6.3%
Q3 24
23.7%
8.9%
Q2 24
12.7%
6.2%
Q1 24
22.3%
7.8%
Net Margin
BTMD
BTMD
HSTM
HSTM
Q4 25
4.2%
Q3 25
17.1%
8.0%
Q2 25
6.5%
7.2%
Q1 25
28.0%
5.9%
Q4 24
7.4%
Q3 24
20.8%
7.8%
Q2 24
-14.4%
5.8%
Q1 24
-8.9%
7.2%
EPS (diluted)
BTMD
BTMD
HSTM
HSTM
Q4 25
$0.05
$0.09
Q3 25
$0.22
$0.20
Q2 25
$0.10
$0.18
Q1 25
$0.37
$0.14
Q4 24
$0.09
$0.16
Q3 24
$0.33
$0.19
Q2 24
$-0.21
$0.14
Q1 24
$-0.12
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTMD
BTMD
HSTM
HSTM
Cash + ST InvestmentsLiquidity on hand
$24.1M
$36.2M
Total DebtLower is stronger
$103.1M
Stockholders' EquityBook value
$-58.5M
$354.0M
Total Assets
$107.6M
$520.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTMD
BTMD
HSTM
HSTM
Q4 25
$24.1M
$36.2M
Q3 25
$28.0M
$53.5M
Q2 25
$19.6M
$52.1M
Q1 25
$41.7M
$77.3M
Q4 24
$39.3M
$59.5M
Q3 24
$38.2M
$57.5M
Q2 24
$26.4M
$46.1M
Q1 24
$78.8M
$52.4M
Total Debt
BTMD
BTMD
HSTM
HSTM
Q4 25
$103.1M
Q3 25
$104.7M
Q2 25
$106.3M
Q1 25
$107.8M
Q4 24
$109.4M
Q3 24
$110.9M
Q2 24
$112.5M
Q1 24
$114.1M
Stockholders' Equity
BTMD
BTMD
HSTM
HSTM
Q4 25
$-58.5M
$354.0M
Q3 25
$-72.8M
$349.2M
Q2 25
$-85.1M
$350.6M
Q1 25
$-90.0M
$362.8M
Q4 24
$-105.9M
$359.4M
Q3 24
$-130.3M
$355.5M
Q2 24
$-143.2M
$349.2M
Q1 24
$-36.0M
$344.9M
Total Assets
BTMD
BTMD
HSTM
HSTM
Q4 25
$107.6M
$520.4M
Q3 25
$111.3M
$499.9M
Q2 25
$104.8M
$500.1M
Q1 25
$123.4M
$524.0M
Q4 24
$122.4M
$510.8M
Q3 24
$101.3M
$502.8M
Q2 24
$92.9M
$499.6M
Q1 24
$160.1M
$511.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTMD
BTMD
HSTM
HSTM
Operating Cash FlowLast quarter
$7.6M
$13.2M
Free Cash FlowOCF − Capex
$6.5M
$13.0M
FCF MarginFCF / Revenue
14.0%
16.3%
Capex IntensityCapex / Revenue
2.3%
0.3%
Cash ConversionOCF / Net Profit
3.87×
TTM Free Cash FlowTrailing 4 quarters
$30.2M
$59.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTMD
BTMD
HSTM
HSTM
Q4 25
$7.6M
$13.2M
Q3 25
$14.1M
$18.0M
Q2 25
$7.1M
$5.0M
Q1 25
$6.5M
$27.1M
Q4 24
$12.4M
$11.2M
Q3 24
$15.6M
$19.1M
Q2 24
$9.9M
$6.5M
Q1 24
$7.4M
$20.9M
Free Cash Flow
BTMD
BTMD
HSTM
HSTM
Q4 25
$6.5M
$13.0M
Q3 25
$13.6M
$17.9M
Q2 25
$5.3M
$2.7M
Q1 25
$4.8M
$26.0M
Q4 24
$10.7M
$11.0M
Q3 24
$14.0M
$18.8M
Q2 24
$7.4M
$6.3M
Q1 24
$6.7M
$20.2M
FCF Margin
BTMD
BTMD
HSTM
HSTM
Q4 25
14.0%
16.3%
Q3 25
28.3%
23.4%
Q2 25
10.8%
3.6%
Q1 25
9.9%
35.4%
Q4 24
21.5%
14.8%
Q3 24
27.3%
25.8%
Q2 24
15.1%
8.8%
Q1 24
14.2%
27.8%
Capex Intensity
BTMD
BTMD
HSTM
HSTM
Q4 25
2.3%
0.3%
Q3 25
1.0%
0.1%
Q2 25
3.7%
3.1%
Q1 25
3.3%
1.4%
Q4 24
3.4%
0.3%
Q3 24
3.0%
0.4%
Q2 24
5.1%
0.2%
Q1 24
1.5%
1.0%
Cash Conversion
BTMD
BTMD
HSTM
HSTM
Q4 25
3.87×
Q3 25
1.72×
2.96×
Q2 25
2.22×
0.93×
Q1 25
0.47×
6.25×
Q4 24
3.34×
Q3 24
1.45×
3.34×
Q2 24
1.55×
Q1 24
4.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTMD
BTMD

Product Revenue$45.3M98%
Disposable Trocars Product Revenue$1.2M3%

HSTM
HSTM

Subscription Services$77.0M97%
Professional Services$2.7M3%

Related Comparisons